Iron Drugs - Worldwide

Iron Drugs Market Definition

The iron drugs market is an important sector of the pharmaceutical industry. This industry deals in the manufacturing and distribution of iron drugs across the world. The main products of this market are oral drugs and intravenous drugs. There are several drugs manufactured in this market, such as iron dextran, iron sucrose, ferric carboxymaltose, and some others. These drugs are designed for various patient groups, including adults and pediatrics. This market is expected to rise significantly with the growth in the healthcare industry across the world.

The growing demand for branded iron drugs, along with a rise in the number of drug approvals around the globe, is driving the market growth. Also, the increased application of dextran-free iron therapeutics coupled with collaborations among companies and rising awareness of iron deficiency in women is a significant contributor to the market expansion. Moreover, the increasing use of iron drugs in the treatment of chronic kidney diseases, inflammatory bowel diseases, cancer, and some others is expected to propel the growth of the iron drugs market.

Advancements in hepcidin, along with the development of new oral iron formulations are expected to create ample growth opportunities for the market players in the future. In May 2023, Emcure Pharmaceuticals launched Orofer FM 750. It is a 750 mg injectable used for treating iron deficiency in patients.